MedPath

山西信谊通制药有限公司

Ownership
-
Established
2001-09-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H14021420
Approval Date
May 20, 2020
NMPA

Troxerutin and Proxyphylline Tablets

Product Name
曲克芦丁羟丙茶碱片
Approval Number
国药准字H14023002
Approval Date
May 20, 2020
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H14021421
Approval Date
May 20, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H14021415
Approval Date
May 20, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H14021416
Approval Date
May 20, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and chlorphenamine Maleate capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H14022999
Approval Date
May 20, 2020
NMPA

Aminophylline Tablets

Product Name
氨茶碱片
Approval Number
国药准字H14021414
Approval Date
May 20, 2020
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H14021426
Approval Date
May 20, 2020
NMPA

Alprazolam Tablets

Product Name
阿普唑仑片
Approval Number
国药准字H14021412
Approval Date
May 20, 2020
NMPA

Moroxydine Hydrochloride Tablets

Product Name
盐酸吗啉胍片
Approval Number
国药准字H14023003
Approval Date
May 20, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.